Influenza Virus Associated Pediatric Acute Respiratory Distress Syndrome: Clinical Characteristics and Outcomes.

acute respiratory distress syndrome influenza mechanical ventilation morbidity mortality pediatric

Journal

Journal of tropical pediatrics
ISSN: 1465-3664
Titre abrégé: J Trop Pediatr
Pays: England
ID NLM: 8010948

Informations de publication

Date de publication:
06 10 2021
Historique:
entrez: 4 11 2021
pubmed: 5 11 2021
medline: 8 4 2022
Statut: ppublish

Résumé

The aim of this multicenter retrospective study was to determine the clinical characteristics, treatment approaches and the course of pediatric acute respiratory distress syndrome (PARDS) which developed associated with the influenza virus in the 2019-20 season. Patients included 1 month to 18 years who were diagnosed with PARDS associated with the influenza virus in the 2019-20 season. Sixty-seven patients were included in the study. The mean age of the patients was 64.16 ± 6.53 months, with 60% of the group <5 years. Influenza A was determined in 54 (80.5%) patients and Influenza B in 13 (19.5%). The majority of patients (73.1%) had a comorbidity. Fifty-eight (86.6%) patients were applied with invasive mechanical ventilation, Pediatric Acute Lung Injury Consensus Conference classification was mild in 5 (8.6%), moderate in 22 (37.9%) and severe in 31 (52.5%) patients. Ventilation was applied in the prone position to 40.3% of the patients, and in nonconventional modes to 24.1%. A total of 22 (33%) patients died, of which 4 had been previously healthy. Of the surviving 45 patients, 38 were discharged without support and 7 patients with a new morbidity. Both Influenza A and Influenza B cause severe PARDS with similar characteristics and at high rates. Influenza-related PARDS cause 33% mortality and 15.5% morbidity among the study group. Healthy children, especially those aged younger than 5 years, are also at risk.

Sections du résumé

BACKGROUND AND OBJECTIVE
The aim of this multicenter retrospective study was to determine the clinical characteristics, treatment approaches and the course of pediatric acute respiratory distress syndrome (PARDS) which developed associated with the influenza virus in the 2019-20 season.
METHODS
Patients included 1 month to 18 years who were diagnosed with PARDS associated with the influenza virus in the 2019-20 season.
RESULTS
Sixty-seven patients were included in the study. The mean age of the patients was 64.16 ± 6.53 months, with 60% of the group <5 years. Influenza A was determined in 54 (80.5%) patients and Influenza B in 13 (19.5%). The majority of patients (73.1%) had a comorbidity. Fifty-eight (86.6%) patients were applied with invasive mechanical ventilation, Pediatric Acute Lung Injury Consensus Conference classification was mild in 5 (8.6%), moderate in 22 (37.9%) and severe in 31 (52.5%) patients. Ventilation was applied in the prone position to 40.3% of the patients, and in nonconventional modes to 24.1%. A total of 22 (33%) patients died, of which 4 had been previously healthy. Of the surviving 45 patients, 38 were discharged without support and 7 patients with a new morbidity.
CONCLUSION
Both Influenza A and Influenza B cause severe PARDS with similar characteristics and at high rates. Influenza-related PARDS cause 33% mortality and 15.5% morbidity among the study group. Healthy children, especially those aged younger than 5 years, are also at risk.

Identifiants

pubmed: 34734291
pii: 6420669
doi: 10.1093/tropej/fmab090
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) [2021]. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Nazik Yener (N)

Division of Pediatric Critical Care, Ondokuz Mayıs University School of Medicine, Samsun, Turkey.

Muhammed Üdürgücü (M)

Division of Pediatric Critical Care, Ondokuz Mayıs University School of Medicine, Samsun, Turkey.

Resul Yılmaz (R)

Division of Pediatric Critical Care, Selcuk University School of Medicine, Samsun, Turkey.

Tanıl Kendirli (T)

Division of Pediatric Critical Care, Ankara University School of Medicine, Ankara, Turkey.

Nazan Ülgen Tekerek (NÜ)

Division of Pediatric Critical Care, Akdeniz University School of Medicine, Antalya, Turkey.

Gültaç Evren (G)

Division of Pediatric Critical Care, Dokuz Eylül University School of Medicine, Izmir, Turkey.

Hatice Feray Arı (HF)

Division of Pediatric Critical Care, Ege University School of Medicine, Izmir, Turkey.

Dinçer Yıldızdaş (D)

Division of Pediatric Critical Care, Cukurova University School of Medicine, Adana, Turkey.

Demet Demirkol (D)

Division of Pediatric Critical Care, Istanbul University School of Medicine, Istanbul, Turkey.

Ethem Pişkin (E)

Division of Pediatric Critical Care, Zonguldak Karaelmas University School of Medicine, Zonguldak, Turkey.

Muhterem Duyu (M)

Division of Pediatric Critical Care, Istanbul Medeniyet University Goztepe Training and Research Hospital, Istanbul, Turkey.

Tahir Dalkıran (T)

Division of Pediatric Critical Care, Nezip Fazil State Hospital, Kahramanmaras, Turkey.

Nihal Akçay (N)

Division of Pediatric Critical Care, İstanbul Bakırköy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.

Nilüfer Yalındağ Öztürk (N)

Division of Pediatric Critical Care, Marmara University School of Medicine, Istanbul, Turkey.

Osman Yeşilbaş (O)

Training and Research Hospital, Bezmialem University, Istanbul, Turkey.

Gürkan Bozan (G)

Division of Pediatric Critical Care, Eskişehir Osmangazi University School of Medicine, Eskişehir, Turkey.

Anar Gurbanov (A)

Division of Pediatric Critical Care, Ankara University School of Medicine, Ankara, Turkey.

Hatice Albayrak (H)

Division of Pediatric Critical Care, Ondokuz Mayıs University School of Medicine, Samsun, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH